Cancer remains one of the leading causes of morbidity and mortality worldwide. Despite significant progress in understanding its molecular underpinnings, translating these insights into effective therapies poses substantial challenges. Effective translation can lead to the development of novel therapies, improved diagnostic tools, and better patient management strategies, ultimately improving survival rates and quality of life for cancer patients.
